|
CALU expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.63424829224823E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.39649999528902E-08 |
| Normal-vs-Stage2 |
1.014240E-02 |
| Normal-vs-Stage3 |
1.823550E-04 |
| Normal-vs-Stage4 |
6.688000E-02 |
| Stage1-vs-Stage2 |
2.387400E-01 |
| Stage1-vs-Stage3 |
3.298500E-02 |
| Stage1-vs-Stage4 |
4.417800E-01 |
| Stage2-vs-Stage3 |
6.325400E-01 |
| Stage2-vs-Stage4 |
9.064000E-01 |
| Stage3-vs-Stage4 |
5.982400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.43285383558123E-12 |
| Normal-vs-AfricanAmerican |
4.21660000000657E-05 |
| Normal-vs-Asian |
1.386170E-01 |
| Caucasian-vs-AfricanAmerican |
7.870600E-01 |
| Caucasian-vs-Asian |
7.196400E-01 |
| AfricanAmerican-vs-Asian |
8.020000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.98010505161983E-11 |
| Normal-vs-Female |
9.49870004873787E-09 |
| Male-vs-Female |
5.198900E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.201400E-03 |
| Normal-vs-Extreme_Weight |
2.32519999998626E-06 |
| Normal-vs-Obese |
5.79509999987238E-07 |
| Normal-vs-Extreme_Obese |
2.597200E-01 |
| Normal_Weight-vs-Extreme_Weight |
6.554000E-01 |
| Normal_Weight-vs-Obese |
7.597600E-02 |
| Normal_Weight-vs-Extreme_Obese |
5.951800E-01 |
| Extreme_Weight-vs-Obese |
8.969500E-02 |
| Extreme_Weight-vs-Extreme_Obese |
4.072000E-01 |
| Obese-vs-Extreme_Obese |
1.537790E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.604500E-03 |
| Normal-vs-Age(41-60Yrs) |
6.3957728002606E-12 |
| Normal-vs-Age(61-80Yrs) |
1.06180000014611E-07 |
| Normal-vs-Age(81-100Yrs) |
4.771600E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.293400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.005430E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.256100E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.991730E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.712990E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.587600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.16340287298544E-11 |
| Normal-VS-Type2 PRCC |
2.160900E-04 |
| Normal-VS-KIRP CIMP |
6.357500E-03 |
| Normal-VS-Unclassified PRCC |
4.42469999994977E-06 |
| Type1 PRCC-VS-Type2 PRCC |
2.301200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
3.437800E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
3.175600E-02 |
| Type2 PRCC-VS-KIRP CIMP |
2.333600E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
8.921300E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
1.060800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.196700E-04 |
| Normal-vs-N1 |
6.586900E-04 |
| Normal-vs-N2 |
1.361550E-01 |
| N0-vs-N1 |
5.911500E-02 |
| N0-vs-N2 |
2.315600E-01 |
| N1-vs-N2 |
2.692000E-01 |
|
|
